TopologView all posts »
Symplicity: A key to treating severe resistant hypertensionDec 3, 2010 11:20 EST
Impressive results from the Symplicity HTN-2 trial, which sought to treat severe resistant hypertension with renal nerve denervation, point to a new mainstay of therapy and pose a number of stimulating questions: Who will perform this operation? How much will it cost? Can the (partially blind) procedure be tweaked and improved? Might treatment also be appropriate for patients with milder hypertension?
What are your thoughts on renal denervation to treat hypertension?
Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010. Published Online: 17 November 2010. Abstract.